GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30215% above fair value
$233.08−10.17 (-4.18%)
Close on Nov 18, 2026Market cap $13.80BP/E –Yield –
Glaukos revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Glaukos's revenue for the twelve months ending Sep 30, 2026 was $690.33M, up 46.9% year over year. For fiscal 2025 it was $507.44M, up 32.3% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $507.44M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $507.44M | +32.3% |
| FY2024 | Dec 31, 2024 | $383.48M | +21.9% |
| FY2023 | Dec 31, 2023 | $314.71M | +11.3% |
| FY2022 | Dec 31, 2022 | $282.86M | -3.8% |
| FY2021 | Dec 31, 2021 | $294.01M | +30.7% |
| FY2020 | Dec 31, 2020 | $224.96M | -5.1% |
| FY2019 | Dec 31, 2019 | $236.98M | +30.7% |
| FY2018 | Dec 31, 2018 | $181.28M | +13.8% |
| FY2017 | Dec 31, 2017 | $159.25M | +39.2% |
| FY2016 | Dec 31, 2016 | $114.40M | +59.5% |
| FY2015 | Dec 31, 2015 | $71.70M | +57.3% |
| FY2014 | Dec 31, 2014 | $45.59M | +117.6% |
| FY2013 | Dec 31, 2013 | $20.95M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $211.03M | +58.0% |
| Q2 FY2026 | Jun 30, 2026 | $185.61M | +49.5% |
| Q1 FY2026 | Mar 31, 2026 | $150.57M | +41.2% |
| Q4 FY2025 | Dec 31, 2025 | $143.12M | +35.7% |
| Q3 FY2025 | Sep 30, 2025 | $133.54M | +38.1% |
| Q2 FY2025 | Jun 30, 2025 | $124.12M | +29.7% |
| Q1 FY2025 | Mar 31, 2025 | $106.66M | +24.6% |
| Q4 FY2024 | Dec 31, 2024 | $105.50M | +28.1% |
| Q3 FY2024 | Sep 30, 2024 | $96.67M | +23.9% |
| Q2 FY2024 | Jun 30, 2024 | $95.69M | +19.0% |
| Q1 FY2024 | Mar 31, 2024 | $85.62M | +15.9% |
| Q4 FY2023 | Dec 31, 2023 | $82.37M | +15.6% |
| Q3 FY2023 | Sep 30, 2023 | $78.05M | +9.5% |
| Q2 FY2023 | Jun 30, 2023 | $80.40M | +10.6% |
| Q1 FY2023 | Mar 31, 2023 | $73.90M | +9.2% |
| Q4 FY2022 | Dec 31, 2022 | $71.23M | -2.7% |
| Q3 FY2022 | Sep 30, 2022 | $71.27M | -4.6% |
| Q2 FY2022 | Jun 30, 2022 | $72.69M | -6.9% |
| Q1 FY2022 | Mar 31, 2022 | $67.68M | -0.4% |
| Q4 FY2021 | Dec 31, 2021 | $73.24M | +0.0% |
| Q3 FY2021 | Sep 30, 2021 | $74.71M | +15.2% |
| Q2 FY2021 | Jun 30, 2021 | $78.09M | +147.5% |
| Q1 FY2021 | Mar 31, 2021 | $67.97M | +22.8% |
| Q4 FY2020 | Dec 31, 2020 | $73.23M | +11.2% |
| Q3 FY2020 | Sep 30, 2020 | $64.83M | +10.8% |
| Q2 FY2020 | Jun 30, 2020 | $31.56M | -46.1% |
| Q1 FY2020 | Mar 31, 2020 | $55.34M | +2.4% |
| Q4 FY2019 | Dec 31, 2019 | $65.85M | +21.8% |
| Q3 FY2019 | Sep 30, 2019 | $58.51M | +33.3% |
| Q2 FY2019 | Jun 30, 2019 | $58.60M | +35.8% |
| Q1 FY2019 | Mar 31, 2019 | $54.03M | +34.6% |
| Q4 FY2018 | Dec 31, 2018 | $54.08M | +29.8% |
| Q3 FY2018 | Sep 30, 2018 | $43.91M | +8.7% |
| Q2 FY2018 | Jun 30, 2018 | $43.16M | +4.5% |
| Q1 FY2018 | Mar 31, 2018 | $40.13M | +11.8% |
| Q4 FY2017 | Dec 31, 2017 | $41.65M | +25.6% |
| Q3 FY2017 | Sep 30, 2017 | $40.41M | – |
| Q2 FY2017 | Jun 30, 2017 | $41.29M | – |
| Q1 FY2017 | Mar 31, 2017 | $35.91M | – |
| Q4 FY2016 | Dec 31, 2016 | $33.17M | – |
See a number that looks wrong?